✦ AI AI Company Comparison

Recursion Pharmaceuticals vs Shein — IPO & Funding Comparison

Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.

⚠️
Some data on this page may be outdated. We're verifying.
Data for Recursion Pharmaceuticals last verified: Jul 15, 2026. Shein: verified Jul 21, 2026.
Metric Recursion Pharmaceuticals Shein
Valuation$2.5B$30-50B
Total Funding$939M$5.2B
IPO StatusPublicPre-IPO
SectorBiotechnologyE-Commerce
StagePublicPre-IPO
HeadquartersSalt Lake City, UTSingapore
CEOChris GibsonChris Xu
The IPO Stack Newsletter

Get Tuesday's IPO moves + one deep-dive in your inbox

Scores, valuations, and signals for Recursion Pharmaceuticals, Shein, and 370+ companies. 5-min read every Tuesday.

Recursion Pharmaceuticals

AI-powered biotech combining biology, chemistry, and machine learning for drug discovery.

IndustryBiotechnology
StagePublic
IPO StatusPublic
Valuation$2.5B
Total Funding$939M
HeadquartersSalt Lake City, UT

Shein

Shein is the world's largest fast fashion company, valued at $66B with $5.2B raised. Track IPO readiness score, funding history, and public market timeline.

IndustryE-Commerce
StagePre-IPO
IPO StatusPre-IPO
Valuation$30-50B
Total Funding$5.2B
HeadquartersSingapore

Get the Full Report on Any Company — One-Time $19

Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.

Get All 375+ Reports — $49/mo

Or buy any single company report for $19

Frequently Asked Questions

What is the Recursion Pharmaceuticals vs Shein valuation in 2026? +

Recursion Pharmaceuticals is valued at $2.5B. Shein is valued at $30-50B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.

Which is more likely to IPO first — Recursion Pharmaceuticals or Shein? +

Recursion Pharmaceuticals is currently already public. Shein filed an S-1 in June 2024 and is actively in the IPO pipeline. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.

How much has each company raised in total funding? +

Recursion Pharmaceuticals has raised $939M. Shein has raised $5.2B.

Are Recursion Pharmaceuticals and Shein in the same sector? +

Recursion Pharmaceuticals operates in Biotechnology, while Shein operates in E-Commerce.

What are the key differences between Recursion Pharmaceuticals and Shein as investments? +

Recursion Pharmaceuticals is a Biotechnology company valued at $2.5B with $939M raised. Shein is a E-Commerce company valued at $30-50B with $5.2B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.

How can I invest in Recursion Pharmaceuticals or Shein before their IPO? +

Accredited investors can access pre-IPO shares in Recursion Pharmaceuticals and Shein through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.

📡 IPO Intelligence
$49/mo — Unlimited Reports + Real-Time Updates
Unlimited company analysis reports — all 375+ companies
Real-time IPO alerts — know the moment S-1s are filed
Verified data updated daily — not chatbot hallucinations
💡 Tracking multiple companies? Full access pays for itself after 3 reports.
$49
per month
Subscribe Now →
Cancel anytime · Secure via Stripe
Institutional Research
$19 — Get the Complete recursion vs shein Analysis Brief
Executive summary & IPO readiness breakdown
Competitive positioning & funding trajectory
Bull / bear thesis with pricing projections
S-1 timeline estimate & risk assessment
$19
One-time
Don't find it useful? Refund within 7 days.
Secure checkout · Stripe · 24h delivery